Compare
Compound-vs-compound comparisons — where the research overlaps, where it diverges, and where no head-to-head study exists at all.
Ozempic vs. Retatrutide: One Signal vs. Three Pathways
Semaglutide amplifies a single GLP-1 signal; retatrutide coordinates three receptor pathways at once — but the two compounds have never been tested head-to-head in the same trial.
4 min
BPC-157 vs. TB-500: Two Halves of Repair
BPC-157 and TB-500 are studied for two distinct repair mechanisms — new blood vessel growth and cell migration — but no study has tested whether combining them outperforms either compound alone.
4 min
Semax and Selank: Research Origins from the Same Russian Institute
Semax and Selank come from the same Moscow institute and share a Pro-Gly-Pro stability modification, but they were engineered for opposite jobs: cognitive activation versus anxiolytic calming.
4 min
Semax vs. “Nature’s Adderall”: Why the Comparison Doesn’t Hold
Amphetamine floods dopamine and norepinephrine within a single dose; Semax works through weeks-long BDNF upregulation — mechanistically, the two have almost nothing in common.
3 min